Neurocrine Biosciences, Inc’s recent filing unveils that its Director Norwalk Leslie V acquired Company’s shares for reported $1.75 million on Dec 15 ’25. In the deal valued at $155.11 per share,11,250 shares were bought.
Then, Lippoldt Darin sold 4,376 shares, generating $698,615 in total proceeds. Upon selling the shares at $159.65, the Chief Legal Officer now owns 43,405 shares.
Before that, DARIN LIPPOLDT bought 4,376 shares. Neurocrine Biosciences, Inc shares valued at $680,512 were divested by the Officer at a price of $155.51 per share.
Citigroup initiated its Neurocrine Biosciences, Inc [NBIX] rating to a Buy in a research note published on October 21, 2025; the price target was $175. A number of analysts have revised their coverage, including Truist’s analysts, who began to cover the stock in late July with a ‘”a Buy”‘ rating. Goldman began covering NBIX with “Buy” recommendation on July 10, 2025. Needham revised its rating on April 15, 2025. It rated NBIX as “a Buy” which previously was an “a Hold”.
Price Performance Review of NBIX
On Monday, Neurocrine Biosciences, Inc [NASDAQ:NBIX] saw its stock jump 0.82% to $154.06. Over the last five days, the stock has lost -0.60%. Neurocrine Biosciences, Inc shares have risen nearly 20.15% since the year began. Nevertheless, the stocks have risen 12.86% over the past one year. While a 52-week high of $160.18 was reached on 12/08/25, a 52-week low of $84.23 was recorded on 04/09/25.
Levels Of Support And Resistance For NBIX Stock
The 24-hour chart illustrates a support level at 151.60, which if violated will result in even more drops to 149.15. On the upside, there is a resistance level at 156.03. A further resistance level may holdings at 158.01.
How much short interest is there in Neurocrine Biosciences, Inc?
A steep rise in short interest was recorded in Neurocrine Biosciences, Inc stocks on 2025-11-28, dropping by -0.13 million shares to a total of 3.99 million shares. Yahoo Finance data shows the prior-month short interest on 2025-10-31 was 4.11 million shares. There was a decline of -3.18%, which implies that there is a negative sentiment for the stock.
